Lisa G Abbott MD

Diabetes, Lipid Metabolism, Thyroid

Northern Nevada Endocrinology

665 Sierra Rose DrReno, NV 89511
Phone+1 775-786-6770
Fax+1 775-786-4901

Dr. Abbott is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abbott's full profile Already have an account?

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Endocrinology, Diabetes, and Metabolism, 1991 - 1993
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1988 - 1991
Keck School of Medicine of the University of Southern CaliforniaClass of 1988

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1989 - Present
NV State Medical License 1993 - 2027

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2014
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013

Clinical Trials

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
A Registry for Participants With Chronic Hypoparathyroidism Start of enrollment: 2013 Jul 30
COMPLETED
Roles: Principal Investigator

Publications & Presentations

PubMed

Early U.S. Real-World Treatment Patterns and Outcomes in Palopegteriparatide Treatment for Patients With Hypoparathyroidism.
Timothy Graham, Dolores M Shoback, Lisa Abbott, Sara Lubitz, Gary Edelson
Endocrine Practice. 2025-12-01
20 citations
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.
Bart L Clarke, Aliya A Khan, Mishaela R Rubin, Peter Schwarz, Tamara Vokes
The Journal of Clinical Endocrinology and Metabolism. 2025-03-17
2 citations
Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1-84) in hypoparathyroidism.
Aliya A Khan, Lisa G Abbott, Intekhab Ahmed, Olulade Ayodele, Claudia Gagnon
JBMR Plus. 2024-03-01